Rate Control in Atrial Fibrillation

Status unconfirmed · Phase 4

Conditions studied: Atrial Fibrillation

In brief

This study will evaluate the efficacy of metoprolol tartrate compared to carvedilol on heart rate control in patients with atrial fibrillation and a rapid ventricular rate.

Key facts

Study ID

NCT02251509

Run by

Creighton University

People needed

20

Starts

2016-12-01

Expected to finish

2017-09-01

Last updated by the study team

2016-06-16

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Permanent atrial fibrillation
• Baseline ventricular rate (prior to treatment) > 110 bpm

You may not qualify if…

• History of accessory tract re-entry tachycardia
• Ejection fraction < 35% or history of NYHA Class III/IV stage C/D heart failure
• Acute coronary syndrome, percutaneous coronary intervention, or cardiac surgery in the past 2 months
• Child-Pugh class B or C hepatic dysfunction
• Uncontrolled hypertension
• Thyroid disease
• Intolerance to beta-blockers
• History of lung disease resulting in hospitalization in the past year

Where it is running

• Creighton University — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.